Filing Details
- Accession Number:
- 0001225208-23-004878
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-18 16:30:55
- Reporting Period:
- 2023-04-17
- Accepted Time:
- 2023-04-18 16:30:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1563565 | Wendy Carruthers | 300 Boston Scientific Way Marlborough MA 01752-1234 | Evp, Human Resources | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-04-17 | 3,448 | $16.31 | 92,084 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-04-17 | 2,960 | $13.08 | 95,044 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-17 | 11,671 | $51.96 | 83,373 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-04-17 | 3,448 | $0.00 | 3,448 | $16.31 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-04-17 | 2,960 | $0.00 | 2,960 | $13.08 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 27,586 | 2025-02-23 | No | 4 | M | Direct | |
| 23,679 | 2024-02-24 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c).
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $51.782 to $52.141, inclusive. The reporting person undertakes to provide upon request by the U.S.Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
Billionaire Hedge Funds
